Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2003
04/10/2003CA2776522A1 Development of a preventive vaccine for filovirus infection in primates
04/10/2003CA2776391A1 Development of a preventive vaccine for filovirus infection in primates
04/10/2003CA2776272A1 Development of a preventive vaccine for filovirus infection in primates
04/10/2003CA2722319A1 Water-in-oil emulsions with ethylene oxide groups, compostions, and methods
04/10/2003CA2466020A1 Rsv gene expression vaccine
04/10/2003CA2463404A1 Fragements of heat shock proteins and their use
04/10/2003CA2462795A1 Secreted proteins
04/10/2003CA2462790A1 Ul16 binding protein 4
04/10/2003CA2462675A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same
04/10/2003CA2462602A1 Double stranded rna as an adjuvant in vaccine compositions
04/10/2003CA2462543A1 Glucagon-like peptides (glp-1) and treatment of respiratory distress
04/10/2003CA2462427A1 Treatment of hepatitis b virus infection with human monoclonal antibodies
04/10/2003CA2462414A1 Products of condensations of hydroxycoumarin derivatives with aromatic and aliphatic dialdehydes, their preparation and antiviral action thereof
04/10/2003CA2462259A1 Mammalian cell-infecting virus vector encoding epitope-bound .beta.2m and utilization thereof
04/10/2003CA2462162A1 Identification of new cd8 epitopes from hiv-1 proteins with therapeuticaal and vaccinal properties against hiv infections
04/10/2003CA2462023A1 Preparation of levofloxacin and forms thereof
04/10/2003CA2461877A1 Method of treatment using ligand-immunogen conjugates
04/10/2003CA2461596A1 Method for treating hepatitis c virus infection in treatment failure patients
04/10/2003CA2461553A1 Water-in-oil emulsions comprising vinyl polymers carrying acidic groups in side chains, compositions, and methods
04/10/2003CA2461254A1 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
04/10/2003CA2460917A1 Human tissue factor antibodies
04/10/2003CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity
04/10/2003CA2460589A1 Method for treating hepatitis c virus infection in treatment failure patients
04/10/2003CA2460006A1 Methods and compositions for treating or preventing bacterial infection
04/10/2003CA2459868A1 Preparation of hiv protease inhibitors
04/10/2003CA2455389A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/10/2003CA2455225A1 Novel proteins and nucleic acids encoding same
04/10/2003CA2425363A1 Benzimidazole compounds, process for producing the same and use thereof
04/09/2003EP1300468A2 TRNA synthetase
04/09/2003EP1300464A1 Fungal cell wall synthesis gene
04/09/2003EP1300424A1 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
04/09/2003EP1300408A1 Antibacterial substituted 7-acylamino-3-(methylhydrazono)methyl-cephalosporins and intermediates
04/09/2003EP1300402A1 Alkoxybenzylamines with antimicrobial properties
04/09/2003EP1300156A2 Otitis media vaccine
04/09/2003EP1299725A2 Herpes zinc finger motifs
04/09/2003EP1299545A2 Drug metabolizing enzymes
04/09/2003EP1299544A2 Fimh adhesin proteins and methods of use
04/09/2003EP1299541A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses
04/09/2003EP1299538A2 Secreted proteins
04/09/2003EP1299534A2 Grf2-binding proteins and applications thereof
04/09/2003EP1299416A2 Antifungal and/or antibacterial peptides, preparation methods and composition containing same
04/09/2003EP1299412A2 Protein modification and maintenance molecules
04/09/2003EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR
04/09/2003EP1299406A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same
04/09/2003EP1299397A1 Novel cephalosporin compounds and process for preparing the same
04/09/2003EP1299396A1 Novel cephalosporin compounds and process for preparing the same
04/09/2003EP1299395A1 Oxazinoquinolones useful for the treatment of viral infections
04/09/2003EP1299387A1 Heterocycle carboxamides as antiviral agents
04/09/2003EP1299386A1 Pyrroloquinolones as antiviral agents
04/09/2003EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function
04/09/2003EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
04/09/2003EP1299382A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
04/09/2003EP1299376A1 Fatty acid synthase inhibitors
04/09/2003EP1299374A1 Novel non-psychotropic cannabinoids
04/09/2003EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase
04/09/2003EP1299361A1 Pyrazole derivatives
04/09/2003EP1299360A2 Heterocycle carboxamides as antiviral agents
04/09/2003EP1299351A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
04/09/2003EP1299350A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
04/09/2003EP1299157A1 Composition and applicator for topical substance delivery
04/09/2003EP1299132A2 Limiting the presence of microorganisms using polymer-bound metal-containing compositions
04/09/2003EP1299117A2 Vaccine against helicobacter pylori
04/09/2003EP1299116A2 Helicobacter pylori with modified lipopolysaccharide biosynthesis
04/09/2003EP1299109A1 Bifunctional antibiotics
04/09/2003EP1299106A2 Method for treatment and prevention of mastitis
04/09/2003EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
04/09/2003EP1299087A1 Microspheres and adjuvants for dna vaccine delivery
04/09/2003EP1299059A1 Method and manufacture of a wound dressing for covering an open wound
04/09/2003EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors
04/09/2003EP1189933B1 Echinocandin derivatives, method for preparing the same and application as antifungal agents
04/09/2003EP1140117B1 Aciclovir compositions containing dimethicone
04/09/2003EP1083922B1 Composition and method for treatment of pseudomonas aeruginosa
04/09/2003EP1049374B1 Tuberculocidal disinfectant
04/09/2003EP1045856B1 Novel aromatic amides, preparation method and application as medicines
04/09/2003EP1001766B1 Compounds for the treatment of ccr5-mediated diseases
04/09/2003EP0963197A4 Guanylhydrazones useful for treating diseases associated with t cell activation
04/09/2003EP0918746B1 Immunotherapeutic agents and their use in the reduction of cytokine levels
04/09/2003EP0906303B1 Ring-fused dihydropyranes, process for the preparation and use thereof
04/09/2003EP0881881B1 Antiparasitic composition for treating and protecting pets
04/09/2003EP0843663B1 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
04/09/2003EP0804552B1 Redirection of cellular immunity by receptor chimeras
04/09/2003EP0784685B1 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
04/09/2003EP0758327B1 Pyranone compounds useful to treat retroviral infections
04/09/2003EP0739345B1 Cyclic polyamines
04/09/2003EP0725824B1 Immunodominant human t-cell epitopes of hepatitis c virus
04/09/2003EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties
04/09/2003CN1409764A Pseudomonas aeruginosa antigens
04/09/2003CN1409726A Type I cytokine receptor TCCR
04/09/2003CN1409721A Treatment of viral infections using LEVOVIRIN
04/09/2003CN1409715A Cyclopenteneone derivatives
04/09/2003CN1409711A Fused naphthalene dinitrogen compound useful as HIV reverse transcriptase inhibitors
04/09/2003CN1409641A DNA- vaccine based on constructs drived from genomes of human and animal pathogens
04/09/2003CN1409639A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder
04/09/2003CN1409631A New formulation
04/09/2003CN1408723A First hypervariable region antigen of hepatitis C and fusion antigen
04/09/2003CN1408436A Recombinant Borrel virus combined vaccine
04/09/2003CN1408435A Method for medicinal matter for nose
04/09/2003CN1408434A Polypeptide and DNA combined vaccine for resisting animal's foot-and-mouth disease and its preparing method
04/09/2003CN1408433A AIDs recombination epitope vaccine and its preparing method
04/09/2003CN1408426A Medicinal tea for preventing and curing tumor and preventing AIDs
1 ... 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 ... 1798